Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Perera Philip — Longboard Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Perera Philip

Perera Philip

CMO at Longboard Pharmaceuticals, Inc. · on record since Mar 11, 2021

Insider trading activity of Perera Philip

Transactions on record: 1; since Feb 11, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 11, 2022

Figures computed from official regulatory filings — methodology.

Companies where Perera Philip has traded

Longboard Pharmaceuticals, Inc.1 tx · Feb 11, 2022

Track record of Perera Philip

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Perera Philip

Co-insiders of Perera Philip

ARENA PHARMACEUTICALS INCLongboard Pharmaceuticals, Inc.
Kaye RandallLongboard Pharmaceuticals, Inc.
Le Goff CorinneLongboard Pharmaceuticals, Inc.
Lind Kevin RobertLongboard Pharmaceuticals, Inc.
Lynch CaseyLongboard Pharmaceuticals, Inc.
Roberts BrandiLongboard Pharmaceuticals, Inc.
SCHNEIDER PHILLIP MLongboard Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

SEKHRI PAUL JLongboard Pharmaceuticals, Inc.

Tiller JaneLongboard Pharmaceuticals, Inc.

Vincent AurentzLongboard Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Longboard Pharmaceuticals, Inc.	Feb 11, 2022	AwardD	95,000	0.00 USD	$0	SEC